Coronavirus updates | October 27, 2021

Schools from Class 1 to reopen from Nov 1 in Delhi; two samples in Karnataka found infected with AY.4.2, a sub-lineage of the Delta variant.

October 27, 2021 07:50 am | Updated 10:14 pm IST

A woman passes a coronavirus test center in Duisburg, Germany. File

A woman passes a coronavirus test center in Duisburg, Germany. File

India logged 13,451 new coronavirus infections, taking the total tally of COVID-19 cases to 3,42,15,653, while the active cases declined to 1,62,661, the lowest in 242 days, according to the Union Health Ministry data updated on Wednesday.

The death toll climbed to 4,55,653 with 585 fresh fatalities, according to the data updated at 8 a.m.

The daily rise in new coronavirus infections has been below 30,000 for 33 straight days and less than 50,000 daily new cases have been reported for 122 consecutive days now.

Also Read | The vaccination milestone and a distant goal

Here are the latest updates:

 

New Delhi

Schools from Class 1 to reopen from Nov 1 in Delhi

DDMA has decided to permit classes from 1 onwards to resume from November 1 at Delhi Schools. Attendance is optional for students depending upon parents' consent.

Schools can operate only at 50% capacity; online classes to be conducted simultaneously for students not attending physically, a statement from Raj Niwas said.

DDMA has directed the Education Department to ensure enforcement of COVID appropriate behaviour as well as 100% vaccination of teachers, staff and transportation personnel.

Citing the availability of “ample stock” of COVID vaccination, the DDMA has directed the government to make efforts to amp up vaccination “to full capacity” than the existing 75,000 daily average.

 

Mandaviya to hold meeting with State health ministers to discuss Covid vaccination, health scheme

Union Health Minister Mansukh Mandaviya will hold a meeting with health ministers of States and UTs on Wednesday to discuss issues related to the Covid emergency response package and scaling up of vaccination.

The meeting will also discuss the PM Ayushman Bharat Health Infrastructure Mission scheme.

"Today, I am meeting the health ministers of the states. COVID-19 vaccination, emergency Covid package and other issues will be discussed in detail.

Discussions will also be held on the 'PM Ayushman Bharat Health Infrastructure Mission' scheme launched by Prime Minister Narendra Modi ji," Mr. Mandaviya said in a tweet in Hindi. - PTI

Karnataka

Two samples in Karnataka found infected with AY.4.2

Although two samples from Karnataka were retrospectively found to be infected with AY.4.2 — a sub-lineage of the Delta variant of SARS-CoV-2 — State health officials and genome sequencing experts say there is no reason to panic as of now.

Scientists have indicated that this new sub-lineage may be more contagious than the original Delta variant. AY.4.2 has now been declared as a ‘Variant under Investigation’ (VuI) in the U.K., where cases are on the rise. However, State health officials said there was no reason to panic as the two samples collected in July were retrospectively found to be infected with this sub-lineage during reanalysis of over 1,300 samples that were genome sequenced in the last few months.

 

 

Active COVID-19 cases lowest in 242 days

India logged 13,451 new coronavirus infections, taking the total tally of COVID-19 cases to 3,42,15,653, while the active cases declined to 1,62,661, the lowest in 242 days, according to the Union Health Ministry data updated on Wednesday.

The death toll climbed to 4,55,653 with 585 fresh fatalities, according to the data updated at 8 a.m.

The daily rise in new coronavirus infections has been below 30,000 for 33 straight days and less than 50,000 daily new cases have been reported for 122 consecutive days now.

The active cases comprise 0.48% of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.19%, the highest since March 2020, the ministry said. - PTI

Brazil

Brazil senators recommend Bolsonaro face charges over COVID

A Brazilian Senate committee recommended on Tuesday that President Jair Bolsonaro face a series of criminal indictments for actions and omissions related to the world's second highest COVID-19 death toll.

The 7-to-4 vote was the culmination of a six-month committee investigation of the government's handling of the pandemic. It formally approved a report calling for prosecutors to try Bolsonaro on charges ranging from charlatanism and inciting crime to misuse of public funds and crimes against humanity, and in doing so hold him responsible for many of Brazil's more than 600,000 COVID-19 deaths. - AP

West Bengal

Bengal’s decision to reopen schools, colleges hailed widely

West Bengal’s decision to reopen colleges and schools from November 15 has been widely welcomed by teachers, students and doctors alike, with many saying the move should have come earlier and that these institutions should have a mechanism for early detection of COVID-19 cases.

“In the U.S. and Europe, the effect of closure of educational institutions has been extensively studied and they are of the opinion that [the long closure] has decreased students’ life expectancy and caused economic damage that will take about 70 years to set right. We have to remember the closure has been much longer in India and therefore the effect is going to be huge,” Dr. Arjun Dasgupta, one of Kolkata’s leading ENT specialists, told The Hindu .

USA

U.S. FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday, October 26, 2021, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds .

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that's been very rare in teens and young adults despite their use of a much higher shot dose. -  AP

 

 

Covaxin nod: WHO seeks more data

The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine.

The technical advisory group will now meet on November 3 for a final assessment.

Hyderabad-based Bharat Biotech had submitted an EOI (Expression of Interest) to the WHO on April 19 for Emergency Use Listing (EUL) of Covaxin. - PTI

 

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.